Bronchial asthma infectious exacerbations;Infekcyjne zaostrzenia astmy oskrzelowej

Polski Merkuriusz Lekarski

Volumn 14, Issue 84, 2003, Pages 566-568

  Hałasa, Józef ^a   Hałasa, Maciej ^a  

^a NONE

Author keywords

Asthma; Bacteria; COPD; Infection; Viruses

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; VACCINE;

ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; ATOPY; BACTERIAL STRAIN; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; HUMAN; HYGIENE; IMMUNOTHERAPY; PARAINFLUENZA VIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; THEORY; VACCINATION;

EID: 0038105185     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Allergenic extracts made from bacteria. Federal Register 1979, 42FR, 58266, 44FR, 1544.
2. Bach J.F.: The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med., 2002, 347, 911-920.
3. Barnes P.J.: Mechanisms in COPD. Differences from asthma. Chest, 2000, 117, 10-14.
4. Berkovich S., Millian S.T., Snyder R.D.: The association of viral and mycoplasma infection with reference to wheezing in the asthmatic child. Am. Allergy, 1970, 28, 43-46.
5. Bianco A. i wsp.: Virus-induced asthma. Monaldi Arch. Chest Dis., 2002, 57, 188-190.
6. Bousquet J., Lockey R.F., Malling H.J.: WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998, 53 suppl. 44, 1-42.
7. Braun-Fahrlander C. i wsp.: Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med., 2002, 347, 869-877.
8. Brook J.: Mikrobiologia I leczenie infekcji górnych dróg oddechowych. Mikrobiologia Medycyna, 1999, 4, 19-29.
9. Busse W.W., Reed C.E.: In vitro studies on the mechanism of respiratory virus-induced asthma. Chest, 1979, 75, suppl. 2, 234-237.
10. Clementsen P., Permin H., Norn S.: Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease. J. Investig. Allergol. Clin. Immunol., 2002, 12, 73-79.
11. Droste J.H.J. i wsp.: Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin. Exp. Allergy, 2000, 30, 1547-1553.
12. Frankeland A.W., Hughes W.H., Govrild R.H.: Autologous bacterial vaccines in treatment of asthma. B.M.J., 1955, 2, 941.
13. Fernandez-Benitez M. i wsp.: Respiratory infection in asthma. J. Investig. Allergol. Clin. Imunol., 2002, 12, 48-51.
14. Garey K.W. i wsp.: Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest, 2003, 123, 261-265.
15. Gawlik R. i wsp.: Immunomodulacja szczepionkami bakteryjnymi w przewleklych chorobach układu oddechowego. Wiad. Lek., 1999, 52, 470.
16. Gern J.E.: Mechanisms of virus-induced asthma. J. Pediatr., 2003, 142, suppl. 2, 9-13.
17. Grossman R.F.: The value of antibiotics and the outcomes of antibiotic therapy in exacerbation of COPD. Chest, 1998, 113, suppl. 4, 249-255.
18. Halasa J. i wsp.: Clinical efficiency of autovaccine in the test treatment of infectious nonatopic asthma and COPD - double blind placebo controlled trial. Allergia Astma Immunologia, 2001, 6, 2, 43-47.
19. Holt P.G., Sly P.D.: Interactions between respiratory tract infections and atopy in the etiology of asthma. Eur. Respir. J., 2002, 19, 538-545.
20. Isaacs D., Joshi P.: Respiratory infections and asthma. Med. J. Aust., 2002, 117, suppl. 50-51.
21. Jacobs J.W. i wsp.: Respiratory Syncytial and other viruses associated with respiratory disease in infants. Lancet, 1977, 8, 71-74.
22. Kalliomaki M. i wsp.: Probiotics in primary prevention of atopic disease: a randomized placebo controlled trial. Lancet, 2001, 357, 1076-1079.
23. Karol H.T.: Respiratory allergy: what are the uncertainties? Toxicology 2002, 181-182, 305-310.
24. Kuberch M. i wsp.: Lower prevalence of asthma and atopy in Turkish children living in Germany. Eur. Respir. J., 1999, 13, 577-582.
25. Lemanske R.F.(Jr.): Viruses and asthma: Inception, exacerbation and possible prevention. J. Pediatr., 2003, 142, suppl. 2, 3-7.
26. Malling H.J.: Bacterial vaccines: anything but placebo. Allergy, 2000, 55, 214-218.
27. Mueller H.L., Lanz M.: Hyposnsitization with bacterial vaccine in infectious asthma. J.A.M.A., 1969, 208, 1379-1383.
28. Nowak D. i wsp.: Prevalence of respiratory symptoms, bronchial hyperresponsiveness and atopy among adults. West and East Germany. Eur. Respir. J., 1996, 9, 2541-2452.
29. Oehling A.: Importance of bacterial infection in the pathogenesis of bronchial asthma. In: From genetics to quality of life. The optimal treatment and management of asthma (ed. Chanez P., Bousquet J., Michel F.B., Godard P.). Seattle W.A. Hogrefe & Huber 1996, 119-126.
30. Oehling A.K.: Bacterial infection as an important triggering factor in bronchial asthma. J. Investig. Allergol. Clin. Immunol., 1999, 9, 1, 6-13.
31. Oehling A. i wsp.: Bacterial immunotherapy of childhood bronchial asthma. Allergol. Immunopathol., 1980, 8, 177-184.
32. Oehling A. i wsp.: The viral factor in the etiology of acute asthma attacks in children. Allergol. Immunopathol., 1981, 9, 1, 29-36.
33. Plusa T. i wsp.: Serological screening tests against Chlamydia pneumoniae in patients with bronchial asthma and chronic obstructive pulmonary disease exacerbation. Int. Rev. Allergol. Clin. Immunol., 2000, 6, 11-13.
34. Renz H., Herz U.: The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur. Resp. J., 2002, 19, 158-171.
35. Sethi S., Murphy T.: Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art-review. Clin. Microbiol. Rev., 2001, 14, 336-363.
36. Skoner D.P.: Viral infection and allergy: lower airway. Allergy, Asthma Proc., 2002, 23, 229-232.
37. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1995, 152, 577-583.
38. Strachan D.P.: Hay fever, hygiene, and house-hold size. B.M.J. 1989, 299, 1259-1260.
39. Strachan D.P.: Family size infection and atopy: the first decade of the hygiene hypothesis". Thorax, 2000, 55, suppl. 1, 2-10.
40. Wark P.A. i wsp.: Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur. Respir. J., 2002, 20, 834-840.
41. Woodruff P.G., Fahy J.V.: Asthma: prevalence, pathogenesis and prospects for novel therapies. J.A.M.A., 2001, 286, 395-398.
42. Wright A.E., Douglas S.R.: On the action exerted upon the Staphylococcus pyogenes by human blood fluids and on the elaboration of protective elements in the human organism in response to inoculations of a staphylococcus vaccine. Proc. Roy. Soc. Lond. 1904, 74, 147.